ALPMF News and Press, Astellas Pharma Inc From 01/16/19

Read more ...

Quick Take Anchiano Therapeutics ( ANCN ) intends to raise $35 million from the sale of ADSs in a U.S IPO, per an F-1 registration statement . The company is pursuing regulatory approvals for its drug treatment pipeline for various cancers. ANCN has generated promising efficacy trial re...

The following slide deck was published by Astellas Pharma, Inc. in conjunction with this Read more ...

Japan's Ministry has approved Amgen (NASDAQ: AMGN ) and co-developer UCB's ( OTCPK:UCBJF )( OTCPK:UCBJY ) EVENITY (romosozumab) for the treatment of osteoporosis in patients at high risk of fracture. More news on: Amgen Inc., UCB S.A., UCB S.A. ADR, Healthcare stocks news, Read more ...

Pfizer ( PFE -0.6% ) and U.S. commercialization partner Astellas Pharma ( OTCPK:ALPMF )( OTCPK:ALPMY )  announce positive results from a Phase 3 clinical trial, ARCHES , evaluating XTANDI (enzalutamide) plus androgen deprivation therapy in men with metastatic hormone-sensitive prost...

Astellas Pharma ( OTCPK:ALPMF ) exercises its exclusive option to acquire immuno-oncology therapy developer Potenza Therapeutics, capping a collaboration agreement that began in 2015. More news on: Astellas Pharma, Inc., Healthcare stocks news, Merger & acquisition news, Read mor...

Please note that I am affiliated with Avisol Capital Partners and their Total Pharma Tracker service. They have also covered the companies in this article in their writings, and I wanted to make readers aware of the potential for overlapping coverage. If you've followed my news cov...

The FDA approves Astellas Pharma's ( OTCPK:ALPMF ) Xospata (gilteritinib) for the treatment of adult patients with relapsed/refractory FLT3 mutation-positive acute myeloid leukemia (AML). More news on: Astellas Pharma, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Privately held Fervent Pharmaceuticals announces the completion of a Phase 2a clinical trial evaluating lead candidate FP-101 for the treatment of vasomotor symptoms (e.g., hot flashes, night sweats) associated with menopause. More news on: Dare Bioscience, Inc., TherapeuticsMD, Astell...

Conducting biopharmaceutical research initiated by Merck ( MRK ) and with a massive market opportunity, Urovant ( UROV ) seems an interesting name to be followed once the IPO goes live. With that, the facts that the company was incorporated in Cayman and Roivant Sciences Ltd. controls the comp...